Schonfeld Strategic Advisors LLC Acadia Pharmaceuticals Inc Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 54,343 shares of ACAD stock, worth $788,516. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,343

Previous 68,339 20.48%

Holding current value

$788,516

Previous $1.26 Million 30.09%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $204,621 - $257,806	-13,996 Reduced 20.48%	54,343 $883,000
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $1.22 Million - $2.11 Million	68,339 New	68,339 $1.26 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $104,887 - $168,454	5,033 Added 6.74%	79,700 $1.66 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $1.33 Million - $1.92 Million	74,667 New	74,667 $1.79 Million
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $441,039 - $922,758	-33,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $709,866 - $932,250	33,900 New	33,900 $821,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $557,428 - $899,388	-33,200 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$15.78 - $24.77 $228,383 - $358,496	-14,473 Reduced 30.36%	33,200 $552,000
Q2 2021 Nov 16, 2021	SELL	$19.4 - $27.42 $54,804 - $77,461	-2,825 Reduced 5.59%	47,673 $1.16 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $680,862 - $962,332	35,096 Added 227.87%	50,498 $1.23 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $385,358 - $846,955	15,402 New	15,402 $397,000
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $1.63 Million - $2.25 Million	-39,629 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $607,339 - $950,532	16,676 Added 72.65%	39,629 $2,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $901,134 - $1.21 Million	22,953 New	22,953 $1.11 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $158,788 - $235,146	-5,017 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $181,665 - $257,873	5,017 New	5,017 $214,000
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $6.61 Million - $13.1 Million	-297,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $4.72 Million - $5.69 Million	202,300 Added 212.95%	297,300 $7.95 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $210,210 - $355,940	13,000 Added 15.85%	95,000 $2.55 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $299,288 - $479,028	-20,900 Reduced 20.31%	82,000 $1.33 Million
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $1.02 Million - $1.71 Million	78,400 Added 320.0%	102,900 $2.14 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $1.19 Million - $1.76 Million	-78,661 Reduced 76.25%	24,500 $375,000
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $2.32 Million - $3.34 Million	103,161 New	103,161 $2.32 Million

Others Institutions Holding ACAD

# of Institutions

290

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.35B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Acadia Pharmaceuticals Inc Transaction History